Lv41
446 积分 2025-05-19 加入
Advancements and challenges in CAR T cell therapy in autoimmune diseases
2小时前
已完结
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study
2天前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
1个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
1个月前
已完结
[Recommendations for management of antiphospholipid syndrome in China]
2个月前
已完结
Toward curing neurological autoimmune disorders: Biomarkers, immunological mechanisms, and therapeutic targets
3个月前
已完结
我国主要神经系统自身免疫性疾病的发病率
3个月前
已完结
Disease-modifying therapies and infectious risks in multiple sclerosis
3个月前
已完结
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
4个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
4个月前
已完结
皖公网安备34019202002308
